pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Ultrasound Guided Erector Spinae Muscle Block in Pediatric Surgeries
Status: NOT_YET_RECRUITING
Conditions: Pediatric Hip Surgery
Interventions: PROCEDURE: Erector Spinae muscle block|PROCEDURE: caudal block
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Mindfulness-based Stress Reduction for Urban Youth
Status: COMPLETED
Conditions: Stress, Psychological
Interventions: BEHAVIORAL: Mindfulness-based stress reduction (MBSR)|BEHAVIORAL: Healthy topics
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Electrical Muscle Stimulation With 1064 nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.
Status: ACTIVE_NOT_RECRUITING
Conditions: Fat Reduction|Muscle Tone Increased
Interventions: DEVICE: EMS|DEVICE: 1064 nm diode laser|DEVICE: RF/PEMF
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Tooth Smart Healthy Start: Oral Health Advocates in Public Housing
Status: COMPLETED
Conditions: Dental Caries in Children
Interventions: BEHAVIORAL: Motivational Interviewing|BEHAVIORAL: Dental Preventive Services
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Study of GWP42006 in People With Focal Seizures - Part A
Status: COMPLETED
Conditions: Epilepsy|Focal Seizures
Interventions: DRUG: GWP42006|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: COPD Online Rehabilitation (CORe)
Status: COMPLETED
Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: BEHAVIORAL: Supervised COPD Rehabilitation (control group)|BEHAVIORAL: Online COPD rehabilitation (experimental)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Goal Management Training in Individuals With PTSD
Status: WITHDRAWN
Conditions: PTSD|Post-traumatic Stress Disorder|Cognitive Impairment|Cognitive Dysfunction|Cognitive Deficit
Interventions: BEHAVIORAL: Goal Management Training (GMT)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
Status: RECRUITING
Conditions: Lymphoma
Interventions: DRUG: Rituximab|DRUG: Lenalidomide|DRUG: Valemetostat
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Status: COMPLETED
Conditions: Breast Cancer|Lymphoma
Interventions: DRUG: Atorvastatin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Clonidine to Prevent Implantable Cardiovertor Defibrillator Firing
Status: WITHDRAWN
Conditions: Ventricular Tachycardia
Interventions: DRUG: clonidine|DRUG: metoprolol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal
Status: COMPLETED
Conditions: Benign Prostatic Hyperplasia
Interventions: DRUG: Harnal-D Tab.|DRUG: Chong Kun Dang Tamsulosin HCl Tab.
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Utility of Induced Sputum Using Hypertonic Saline to Evaluate Infection and Inflammation in Cystic Fibrosis
Status: COMPLETED
Conditions: Cystic Fibrosis
Interventions: DRUG: Hypertonic Saline
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy
Status: RECRUITING
Conditions: Acute Coronary Syndrome|CYP2C19 Polymorphism
Interventions: DRUG: Clopidogrel
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Controlled Internal Convection in Low Flow Hemodialysis of Dialysate: Removal of Beta-2-microglobulin
Status: UNKNOWN
Conditions: Daily Home Hemodialysis
Interventions: PROCEDURE: home hemodialysis session with 9L internal convection
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Status: UNKNOWN
Conditions: Leukemia
Interventions: BIOLOGICAL: recombinant interferon alfa|DRUG: busulfan|DRUG: cytarabine|DRUG: hydroxyurea|DRUG: idarubicin|PROCEDURE: allogeneic bone marrow transplantation|PROCEDURE: autologous bone marrow transplantation|PROCEDURE: peripheral blood stem cell transplantation|RADIATION: radiation therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: Neoadjuvant Fruquintinib Plus Tislelizumab Combined With mCapeOX Versus CapeOX for Mid-high pMMR/MSS Locally Advanced Rectal Cancer
Status: NOT_YET_RECRUITING
Conditions: Rectal Cancer
Interventions: DRUG: CapeOX|DRUG: Fruquintinib and Tislelizumab combined with mCapeOX
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Feasibility and Usability of a Pedometer in a Cardiovascular Disease Prevention Program for French-speaking Canadians
Status: COMPLETED
Conditions: Cardiovascular Disease
Interventions: DEVICE: PiezoRx medical grade pedometer
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: ACTIVE_NOT_RECRUITING
Conditions: Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma
Interventions: DRUG: dexamethasone|DRUG: carfilzomib|DRUG: lenalidomide|PROCEDURE: autologous hematopoietic stem cell transplantation|OTHER: laboratory biomarker analysis
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients
Status: ACTIVE_NOT_RECRUITING
Conditions: Coronavirus Disease 2019 (COVID-19)
Interventions: DRUG: Raphamin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD
Status: TERMINATED
Conditions: Diabetes Mellitus|Chronic Obstructive Pulmonary Disease
Interventions: DRUG: Subcutaneous Insulin|DRUG: Inhaled Insulin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Benralizumab Initiated During Severe Asthma Attack
Status: UNKNOWN
Conditions: Asthma Attack|Asthma
Interventions: DRUG: Benralizumab 30 MG/ML [Fasenra]|DRUG: Placebos
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Pressure Support Ventilation (PSV) Versus Neurally Adjusted Ventilator Assist (NAVA) During Acute Respiratory Failure (ARF)
Status: COMPLETED
Conditions: Respiratory Failure
Interventions: OTHER: NAVA during Non invasive ventilation|OTHER: PSV during Non invasive ventilation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas
Status: COMPLETED
Conditions: Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult T-cell Leukemia/Lymphoma|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Mycosis Fungoides/Sezary Syndrome|Stage III Small Lymphocytic Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult T-cell Leukemia/Lymphoma|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Mycosis Fungoides/Sezary Syndrome|Stage IV Small Lymphocytic Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific|Waldenström Macroglobulinemia
Interventions: DRUG: alvespimycin hydrochloride|OTHER: laboratory biomarker analysis
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: S&P of Q-Fix™ All-Suture Anchor System
Status: COMPLETED
Conditions: Bankart Lesion|Acetabular Labrum Tear|SLAP Lesion|Acromioclavicular Sprain|Capsular Shift/Capsulolabral Reconstruction|Deltoid Repair|Rotator Cuff Repair|Bicep Tendinitis|Extra-capsular Repair|Medial Collateral Ligament|Lateal Collateral Ligament|Posterior Oblique Ligament|IBT|Vastus Medialis|Obliquus Advancement|Joint Capsule Closure
Interventions: DEVICE: The Q-Fix™ All-Suture Anchor
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Effects of Oxytocin on Reinforcement Learning
Status: UNKNOWN
Conditions: Learning Disabilities
Interventions: DRUG: intranasal oxytocin|DRUG: intranasal placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: High-intensity Interval Training in Patients With Atrial Fibrillation
Status: UNKNOWN
Conditions: Atrial Fibrillation
Interventions: OTHER: High-intensity interval training|OTHER: Moderate-intensity continuous training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Rescue of Nephrons With ALE.F02 (RENAL-F02)
Status: RECRUITING
Conditions: Glomerulonephritis Rapidly Progressive
Interventions: BIOLOGICAL: ALE.F02|DRUG: Rituximab|DRUG: GlucoCorticoid|DRUG: Cyclophosphamid|DRUG: Placebo|DRUG: Immunosuppressive Agents
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The Effects of Oral Dipyridamole Treatment on the Innate Immune Response During Human Endotoxemia
Status: COMPLETED
Conditions: Endotoxemia
Interventions: DRUG: Dipyridamole|DRUG: Placebo|OTHER: LPS
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Intraarticular Lumbar Joint Corticosteroid Injection(s) as a Treatment of Chronic Low Back Pain in a Selected Population
Status: COMPLETED
Conditions: Low Back Pain
Interventions: DRUG: Intra-articular corticosteroid injection|DRUG: Intra-articular saline injection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis.
Status: RECRUITING
Conditions: Healthy|Plaque Psoriasis
Interventions: BIOLOGICAL: CAN10|BIOLOGICAL: CAN10 - Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Pembrolizumab in Treating Patients With Malignant Mesothelioma
Status: ACTIVE_NOT_RECRUITING
Conditions: Biphasic Mesothelioma|Epithelioid Mesothelioma|Peritoneal Malignant Mesothelioma|Pleural Biphasic Mesothelioma|Pleural Epithelioid Mesothelioma|Pleural Malignant Mesothelioma|Pleural Sarcomatoid Mesothelioma|Recurrent Peritoneal Malignant Mesothelioma|Recurrent Pleural Malignant Mesothelioma|Sarcomatoid Mesothelioma
Interventions: BIOLOGICAL: Pembrolizumab|OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacogenomic Study
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Propofol/Dexmedetomidine Versus Desflurane Effects on Post Hepatectomy Hepatocellular Injury
Status: RECRUITING
Conditions: Hepatectomy
Interventions: DRUG: Propofol, dexmedetomidine|DRUG: Desflurane
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients
Status: COMPLETED
Conditions: Kidney Transplantation|Liver Transplantation
Interventions: BIOLOGICAL: Prevenar13|BIOLOGICAL: Pneumovax
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Its Effects on Motor Functions
Status: ACTIVE_NOT_RECRUITING
Conditions: Duchenne Muscular Dystrophy
Interventions: OTHER: Modified Mini Mental Test:|OTHER: The Controlled Oral Word Association Test|OTHER: The Central Nervous System Vital Signs|OTHER: Conners' Parent Rating Scale-48 (Parent Report)|OTHER: Child Behavior Checklist 6-18 ages (Parent Report)|OTHER: Strengths and Difficulties Questionnaire (Self-Reported)|OTHER: Brooke Lower Extremity Functional Classification|OTHER: Motor Function Measurement-32 Items|OTHER: Four Square Step Test|OTHER: Six Minutes Walk Test|OTHER: Timed Performance Test
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: 22G-ProCore vs 22G-Standard Needle in Diagnosis of Lymphadenopathy by EBUS-TBNA
Status: UNKNOWN
Conditions: Lymph Node Disease
Interventions: DEVICE: 22G-ProCore Endobronchial Ultrasound Needle|DEVICE: 22G-Standard Endobronchial Ultrasound Needle
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Minds and Mentors Program (MiMP)- R61
Status: COMPLETED
Conditions: Opioid-use Disorder|Medication Assisted Treatment|Substance Use Disorders
Interventions: BEHAVIORAL: Mindfulness based relapse prevention and peer mentoring
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx
Status: COMPLETED
Conditions: Obstructive Sleep Apnea|Amyotrophic Lateral Sclerosis|Muscular Dystrophies|Healthy
Interventions: DEVICE: Transmembrane EMG Oropharynx Probe
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients
Status: TERMINATED
Conditions: Heart Failure
Interventions: OTHER: Discharge medication counseling from a pharmacist|OTHER: Home medication if needed|OTHER: Follow-up visit at Medication Therapy Management clinic
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission
Status: COMPLETED
Conditions: HIV Infections
Interventions: DRUG: Erythromycin|DRUG: Nevirapine|DRUG: Ampicillin sodium|DRUG: Metronidazole
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION
Clinical trial: BI 655066/ABBV-066/Risankizumab Compared to Placebo in Patients With Active Psoriatic Arthritis
Status: COMPLETED
Conditions: Arthritis, Psoriatic
Interventions: DRUG: risankizumab|DRUG: placebo for risankizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)
Status: COMPLETED
Conditions: Chronic Hepatitis C|Hepatitis C Virus|Compensated Cirrhosis
Interventions: DRUG: ABT-493|DRUG: ABT-530|DRUG: ABT-450/r/ABT-267, ABT-333|DRUG: Ribavirin (RBV)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Evaluation of the Hypoallergenicity of a New Formula Based on Hydrolyzed Rice Proteins
Status: COMPLETED
Conditions: Cow Milk Allergy
Interventions: DIETARY_SUPPLEMENT: rice formula|DIETARY_SUPPLEMENT: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Botulinum-assisted Orbital Fat Augmentation With PRP (Platelet-rich-plasma)
Status: COMPLETED
Conditions: Orbital Atrophy
Interventions: PROCEDURE: fat, PRP, botulinum toxin|DRUG: botulinum toxin|DEVICE: PRP
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
Status: COMPLETED
Conditions: Dermatitis, Atopic
Interventions: DRUG: PF-04965842 100 mg|DRUG: PF-04965842 200 mg|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effect of Nutritional Support and Early Rehabilitation on Sepsis
Status: NOT_YET_RECRUITING
Conditions: Life Quality|Hospital Mortality
Interventions: DIETARY_SUPPLEMENT: high protein|BEHAVIORAL: rehabilitation|DIETARY_SUPPLEMENT: standard protein
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: TRANSfusion in Patients With Onco-hematological Malignancies ResusciTated From Septic Shock
Status: COMPLETED
Conditions: Septic Shock|Anemia|Cancer
Interventions: BIOLOGICAL: Liberal Red blood cell transfusion|BIOLOGICAL: Restrictive Red blood cell transfusion
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II Study
Status: UNKNOWN
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Eribulin|DRUG: Tislelizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
Status: RECRUITING
Conditions: Kallmann Syndrome|Hypogonadotropic Hypogonadism|Hypothalamic Amenorrhea|Polycystic Ovarian Syndrome|Precocious Puberty|Cleft Lip and Palate|Cleft Palate|Cleft Lip
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Oxidative Stress and Endothelial Dysfunction in Obstructive Sleep Apnea
Status: TERMINATED
Conditions: Obstructive Sleep Apnea Syndrome|Endothelial Dysfunction|Oxidative Stress|Intermittent Hypoxia|Cardiovascular Risk
Interventions: DEVICE: CPAP device|DEVICE: Placebo device
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Clinical Utility of Methylation-based Prognostic Assay for Barrett's Esophagus
Status: ACTIVE_NOT_RECRUITING
Conditions: Barrett Esophagus|Esophageal Cancer
Interventions: OTHER: Educational materials on validated methylation assay
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: DIAGNOSTIC
Clinical trial: Telemedicine Efficacy in Medication Adherence in Post-ischemic Stroke Patients
Status: UNKNOWN
Conditions: Stroke|Compliance, Patient|Compliance, Treatment|Compliance, Medication
Interventions: OTHER: telemedicine neurology consultation|OTHER: in-person neurology consultation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Comparative Effectiveness of Unilateral vs. Bilateral Pulmonary Collapse in Cardiac De-airing
Status: COMPLETED
Conditions: Brain Ischemia|Reduction of Cerebral Air Emboli
Interventions: PROCEDURE: Bilateral Open Pleurae|PROCEDURE: Right Pleura Open
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion
Status: COMPLETED
Conditions: Ischemic Central Retinal Vein Occlusion
Interventions: DRUG: Ranibizumab (Lucentis)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Subthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson's Disease
Status: COMPLETED
Conditions: Parkinson's Disease
Interventions: OTHER: MRIgHIFU unilateral subthalamotomy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Inflammation and Depression Following SCI
Status: NOT_YET_RECRUITING
Conditions: Spinal Cord Injury|Depression
Interventions: DEVICE: Active Transcutaneous Auricular Vagus Nerve Stimulation|DEVICE: Sham Transcutaneous Auricular Vagus Nerve Stimulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects
Status: COMPLETED
Conditions: SARS-CoV-2
Interventions: BIOLOGICAL: BNT162b1|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Effects of Unblocking the Full Potential of Percept PC IPG
Status: ACTIVE_NOT_RECRUITING
Conditions: Parkinson Disease
Interventions: OTHER: Programming DBS using Percept PC neurostimulator's full potential
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study
Status: COMPLETED
Conditions: Diabetes Mellitus|Type 1 Diabetes|Insulin Pump
Interventions: DEVICE: t:slim insulin pump with predictive low glucose suspend
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
Clinical trial: Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS
Status: RECRUITING
Conditions: P53 Mutation|Myeloid Malignancy|MDS|Aml
Interventions: DRUG: Decitabine|DRUG: Arsenic Trioxide
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Itraconazole on the Pharmacokinetics of Apatinib
Status: COMPLETED
Conditions: Neoplasms
Interventions: DRUG: Apatinib Mesylate Tablets|DRUG: Itraconazole Capsules
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy
Status: RECRUITING
Conditions: Iron Deficiency Anemia of Pregnancy|Iron Storage Disease
Interventions: DRUG: Niferex
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma
Status: TERMINATED
Conditions: Hilar Cholangiocarcinoma
Interventions: COMBINATION_PRODUCT: PDT-Deuteporfin（6 hour)|COMBINATION_PRODUCT: PDT-Deuteporfin（9 hour)|DEVICE: stenting
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive Impairment
Status: COMPLETED
Conditions: Sleep Disorder
Interventions: DIAGNOSTIC_TEST: Structural 3T MRI|DIAGNOSTIC_TEST: MRI Based Perfusion Imaging|DIAGNOSTIC_TEST: VR-CO2 MRI Scans
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis
Status: COMPLETED
Conditions: Asthma|Allergic Rhinitis
Interventions: DRUG: Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo|DRUG: Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase|DRUG: QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo|DRUG: QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris|DRUG: Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase|DRUG: Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies
Status: COMPLETED
Conditions: Metastatic Cancer|Solid Tumor
Interventions: DRUG: Sym021|DRUG: Sym022|DRUG: Sym023|DRUG: Irinotecan Hydrochloride
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)
Status: ACTIVE_NOT_RECRUITING
Conditions: Crohn Disease|Ulcerative Colitis|Inflammatory Bowel Diseases
Interventions: OTHER: Resistant Starch|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Effect of Subanesthetic Dose of Esketamine on Sleep Quality and Recovery of Gastrointestinal Function in Patients Undergoing General Anesthesia Laparoscopic Uterine Surgery in the Early Postoperative Period
Status: COMPLETED
Conditions: Patients Undergoing General Anesthesia Laparoscopic Uterine Surgery
Interventions: DRUG: esketamine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma
Status: ACTIVE_NOT_RECRUITING
Conditions: Breast Carcinoma|Breast Cancer|Stage 0 Breast Cancer|Stage I Breast Cancer
Interventions: RADIATION: External Beam Accelerated Partial Breast Irradiation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Direct Access Study: Access to Hormonal Birth Control Through Community Pharmacies
Status: UNKNOWN
Conditions: Contraception
Interventions: BEHAVIORAL: Contraceptive Screening by Pharmacist|BEHAVIORAL: Contraceptive Prescribing by Pharmacist
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Text Message Program to Improve Eating Behaviors Among African Americans in New Orleans
Status: COMPLETED
Conditions: Diet Habit|Health Behavior|Health Knowledge, Attitudes, Practice
Interventions: BEHAVIORAL: Texts to support healthy eating|BEHAVIORAL: Texts to support physical activity
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1
Status: COMPLETED
Conditions: Pancreas Adenocarcinoma|Cholangiocarcinoma
Interventions: DRUG: CRGD-ZW800-1|DEVICE: Intraoperative near-infrared fluorescence imaging
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Antitumor Activity and Safety of BEBT-109, a Novel EGFR Inhibitor, in Previously Treated NSCLC
Status: COMPLETED
Conditions: NSCLC
Interventions: DRUG: BEBT-109
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Single Ascending Dose Study of PRX002 in Healthy Subjects
Status: COMPLETED
Conditions: Parkinson's Disease
Interventions: DRUG: PRX002|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Determine the Effects of Itraconazole on the Pharmacokinetics (PK) of DS-8500 in Healthy Subjects
Status: COMPLETED
Conditions: Pharmacokinetics
Interventions: DRUG: DS-8500a|DRUG: Itraconazole
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: 4 Week Treatment With Three Oral Doses of BI 10773 in Patients With Type 2 Diabetes
Status: COMPLETED
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: BI 10773 low dose|DRUG: placebo to BI 10773|DRUG: BI 10773 medium dose|DRUG: BI 10773 high dose
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation
Status: COMPLETED
Conditions: Essential Tremor
Interventions: DEVICE: Cathodal cerebellar transcranial direct current stimulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: InterGard Synergy Post-Marketing Surveillance Study
Status: UNKNOWN
Conditions: Aortic Aneurysm, Abdominal|Occlusive Disease of Artery of Lower Extremity
Interventions: DEVICE: InterGard Synergy Vascular Graft
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer
Status: RECRUITING
Conditions: Biliary Tract Neoplasms Immunotherapy
Interventions: DRUG: Pembrolizumab,Lenvatinib and Gemox Chemotherapy（Gemcitabine and Oxaliplatin）|DRUG: Pembrolizumab and Lenvatinib|DRUG: Pembrolizumab and Gemox Chemotherapy（Gemcitabine and Oxaliplatin）
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of Azeol Nasal Spray Versus Placebo in the Treatment of Early Symptoms of Common Cold in Adults
Status: COMPLETED
Conditions: Nasal Congestion
Interventions: DEVICE: Azeol spray nasal|DEVICE: Placebo nasal spray
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema
Status: COMPLETED
Conditions: Diabetic Retinopathy|Macula Edema
Interventions: DEVICE: Yellow micro-pulse laser|DEVICE: Diode micro-pulse laser
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients
Status: TERMINATED
Conditions: Breast Cancer|Musculoskeletal Disease
Interventions: DRUG: Vitamin D3|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Status: COMPLETED
Conditions: Eosinophilic Esophagitis|Eosinophilic Gastritis|Eosinophilic Gastroenteritis|Eosinophilic Colitis
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease
Status: UNKNOWN
Conditions: Gastro-esophageal Reflux|Reflux, Gastroesophageal
Interventions: PROCEDURE: Anti Reflux Mucosa Ablation
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison of Gongs and Kaltenborn Mobilization on Neck Pain
Status: RECRUITING
Conditions: Mechanical Neck Pain
Interventions: OTHER: Gongs mobilization + conventional physical therapy|OTHER: Kaltenborn mobilization along with traction + conventional therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Magnetic Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia
Status: UNKNOWN
Conditions: Schizophrenia
Interventions: DEVICE: Paired Pulse|DEVICE: Paired Pulse
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluation of the Effect of Intra-ligamentary Injection of Diclofenac Potassium Versus Articaine on Anaesthetic Efficacy in Mandibular Molars With Symptomatic Irreversible Pulpitis.
Status: NOT_YET_RECRUITING
Conditions: Teeth With Acute Irreverseble Pulpitis
Interventions: DRUG: Diclofenac Potassium
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Russian Study of the Effect of Continuous Positive Airway Pressure (CPAP) in Hypertension
Status: COMPLETED
Conditions: Obstructive Sleep Apnea Syndrome|Hypertension
Interventions: PROCEDURE: cPAP
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer
Status: ENROLLING_BY_INVITATION
Conditions: Lower Urinary Tract Symptoms|Intravenous Drug Usage|Bladder Cancer|Herbal Interaction
Interventions: DIETARY_SUPPLEMENT: JING SI HERBAL TEA|DIETARY_SUPPLEMENT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT
Clinical trial: The Effect of Breathing Exercise on Fatigue in Heart Failure Patients
Status: COMPLETED
Conditions: Heart Failure|Fatigue
Interventions: OTHER: Breathing exercise|OTHER: Placebo Breathing Group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Interest of PReOPerative Immunonutrition in Liver Surgery for Cancer
Status: COMPLETED
Conditions: Hepatectomy|Elective Hepatectomy|Malignant Tumors
Interventions: DIETARY_SUPPLEMENT: Oral immunonutrition|DIETARY_SUPPLEMENT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Time-Restricted Feeding Plus Resistance Training in Active Females
Status: COMPLETED
Conditions: Healthy Active Females
Interventions: DIETARY_SUPPLEMENT: Beta-hydroxy beta-methylbutyrate|OTHER: Resistance Training|DIETARY_SUPPLEMENT: Protein Supplementation|BEHAVIORAL: Time-Restricted Feeding
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: The Effect of Soft Tissue Mobilization in Myofascial Neck Pain
Status: COMPLETED
Conditions: Neck Pain
Interventions: DEVICE: Dr. Gene's Health and Wellness|PROCEDURE: Muscle Energy Technique|PROCEDURE: Static stretching and Cervical non thrust manipulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification
Status: COMPLETED
Conditions: Ocular Inflammation
Interventions: DRUG: triamcinolone acetonide|DRUG: Maxitriol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
Status: WITHDRAWN
Conditions: Narrative Medicine|Chronic Disease|Terminal Illness|Cancer|Diabetes Mellitus|Cystic Fibrosis|Rheumatologic Disorder|Oncologic Disorders|Hematologic Diseases
Interventions: BEHAVIORAL: Patient Provider Orientation Scale|BEHAVIORAL: Interview performed by MHP student
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
Status: COMPLETED
Conditions: Refractory Myasthenia Gravis
Interventions: DRUG: Rituximab (Rituxan)
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Hypoglycemia and Autonomic Nervous System Function- B2
Status: ACTIVE_NOT_RECRUITING
Conditions: Hypoglycemia|Type2 Diabetes
Interventions: OTHER: Hyperinsulinemic Hypoglycemic Clamp
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of Systematic Proprioceptive-tactile Stimulation With Use of the Protac MyFit®
Status: UNKNOWN
Conditions: Sensory Processing Disorder|Children
Interventions: DEVICE: Protac Myfit®
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment
Status: NOT_YET_RECRUITING
Conditions: Chemotherapy-Related Cognitive Impairment|DL-3-n-butylphthalide
Interventions: DRUG: DL-3-n-butylphthalide|DRUG: Empty Medication Capsules
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effectiveness and Safety of Thread Embedding Acupuncture for Drug Resistant Epilepsy
Status: UNKNOWN
Conditions: Epilepsy, Drug Resistant|Acupuncture Therapy
Interventions: OTHER: Thread Embedding Acupuncture (TEA)|OTHER: Sham-TEA (STEA)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study
Status: RECRUITING
Conditions: Covid19|SARS-CoV Infection|Transplantation Infection
Interventions: DIAGNOSTIC_TEST: SARS-CoV-2 IgG
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Treatment of Social Phobia Over the Internet
Status: COMPLETED
Conditions: Social Phobia
Interventions: BEHAVIORAL: Internet-based cognitive behavioural therapy (iCBT)|BEHAVIORAL: Internet-based computerized attention training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults
Status: COMPLETED
Conditions: Hyperhidrosis
Interventions: DRUG: Oxybutynin 3% gel
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma
Status: COMPLETED
Conditions: HCC
Interventions: DRUG: Donafenib(200mg)|DRUG: Donafenib(300mg)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Avandamet Bioequivalence Study Brazil - Fed Administration
Status: COMPLETED
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: Rosiglitazone Maleate + Metformin 2 miligrams (mg) + 500 mg|DRUG: Rosiglitazone Maleate + Metformin 4 miligrams (mg) + 1000 mg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Presential Vs Online Group-based Psychosocial Treatment for Breast Cancer Survivors.
Status: COMPLETED
Conditions: Breastcancer|Emotional Disorder|Distress
Interventions: BEHAVIORAL: Positive Psychotherapy|BEHAVIORAL: Positive Online Psychotherapy|BEHAVIORAL: Cognitive Behavioral Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: TRIPLE (CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study on Efficacy and Safety of HST101 in Chinese Patients With Hypercholesterolemia
Status: NOT_YET_RECRUITING
Conditions: Hypercholesterolemia|Dyslipidemias|Primary Hypercholesterolemia|Heterozygous Familial Hypercholesterolemia|Hyperlipidemia; Mixed|Metabolic Disease|ASCVD
Interventions: DRUG: Lerodalcibep|DRUG: matching placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Clinical Study of De-Stress & Chill Gummies in Reducing Stress
Status: NOT_YET_RECRUITING
Conditions: Stress|Anxiety
Interventions: OTHER: De-Stress and Chill Gummies-U001|OTHER: De-Stress and Chill Gummies-I001|OTHER: Placebo Gummies-001
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: L-Citrulline in Patients With Post-Polio Syndrome
Status: COMPLETED
Conditions: Post-Polio Syndrome
Interventions: DRUG: 15g L-citrulline daily p.o.|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: COMPLETED
Conditions: Chronic Obstructive Pulmonary Disease
Interventions: DRUG: NVA237|DRUG: Tiotropium|DRUG: Placebo to NVA237|DRUG: Placebo to tiotropium|DRUG: Salbutamol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)
Status: ACTIVE_NOT_RECRUITING
Conditions: COVID-19
Interventions: BIOLOGICAL: Recombinant COVID-19 vaccine (Sf9 cells)|OTHER: Placebo control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Citalopram for Reflux Hypersensitivity and Functional Heartburn
Status: UNKNOWN
Conditions: GERD
Interventions: DRUG: Citalopram 20mg|DRUG: Placebo Oral Tablet
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT